MedPath

Effectiveness Evaluation in Thrombus Aspiration in Patients With STEMI and High Thrombotic Load

Not Applicable
Conditions
STEMI
Registration Number
NCT05043597
Lead Sponsor
Shenzhen People's Hospital
Brief Summary

This study intends to evaluate thrombus on the basis of different methods for evaluating thrombus load The effect of aspiration on the prognosis of STEMI patients with high thrombotic load Provide a basis for the standardized use of aspiration; at the same time, discover the best benefit groups for thrombus aspiration

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
3838
Inclusion Criteria
  • (1) Age ≥ 18 years; (2) Voluntary signing of informed consent; (3) Onset of 12 hours STEMI patients who underwent PCI reperfusion therapy within time; (4) The guidewire passes through the lesion and the blood Heavy embolism load (TIMI thrombus classification ≥ 3).
Exclusion Criteria
  • (1) Hemodynamics is unstable or there is cardiogenic shock; (2) After thrombolytic therapy; (3) The expected survival time is less than 6 months due to non-cardiac diseases; (4) Past trips Coronary artery bypass graft patients; (5) Participate in other drug and device research within 30 days; (6) Before surgery, clear active gastrointestinal bleeding or other contraindications for taking dual antiplatelet drugs (7) Patients deemed unsuitable for enrollment by other researchers

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Adverse cardiovascular events3 years

Including cardiogenic death, recurring myocardial infarction Stent thrombosis or target vessel revascularization

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shenzhen People's Hospital

🇨🇳

Shenzhen, China

Shenzhen People's Hospital
🇨🇳Shenzhen, China

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.